ABSTRACT Baicalein, one of the major flavonoids in Scutellaria baicalensis (Chinese Skullcap), is well known for its effects on cell proliferation, apoptosis, and inflammation. Here we show that baicalein also inhibits the adipogenesis of 3T3-L1 preadipocytes. Baicalein inhibited triglyceride accumulation during adipogenesis and significantly decreased the mRNA expression of fatty acid-binding protein (FABP), a marker of adipogenesis. Microarray analysis revealed that several genes, which are differentially expressed during adipogenesis, were modulated by baicalein treatment in 3T-L1 cells. The expression of FABP, apolipoprotein D, and insulin-like growth factor 2, which was markedly up-regulated during adipogenesis, was down-regulated by baicalein. Cyclooxygenase (COX)-2 mRNA expression, which was decreased during adipogenesis, was up-regulated by baicalein. These COX-2 mRNA expression patterns were mirrored by the expression of COX-2 protein and its enzymatic activity. NS-398, a COX-2 inhibitor, partially abrogated the baicalein-induced inhibition of adipogenensis. Thus, the anti-adipogenic effect of baicalein may be mediated by its ability to enhance the expression of COX-2, which is normally down-regulated during adipogenesis.
INTRODUCTION
B AICALEIN (FIG. 1) , one of the major flavonoids in Scutellaria baicalensis (Chinese Skullcap), is known to affect a variety of biological processes. It has been shown that baicalein arrests the cell cycle in Hep G2 cells at the G1/S phase by decreasing the expression of cyclin A, cyclin D, and cyclin-dependent kinases. [1] [2] [3] Baicalein was also reported to inhibit cell proliferation in human T-lymphocytoleukemia cells by suppressing platelet-derived growth factor-A mRNA expression. 4 In addition, it has been found to induce apoptosis in Hep G2 cells by elevating caspase-3 and by decreasing Bcl-2 expression. 5, 6 Baicalein also has antioxidant and anti-inflammatory properties. Shao et al. 7 showed with an ischemia-reperfusion model that the presence of baicalein decreases the formation of reactive oxygen species in hypoxic conditions. Baicalein was also found to reduce nitric oxide formation in microglial cells in response to endotoxin/cytokine treatment by repressing inhibitory nitric oxide synthase mRNA expression. 8 In addition, baicalein decreased the production of pro-inflammatory interleukins and eotaxin, [9] [10] [11] and suppresses the synthesis of prostaglandin E by inhibiting the mitogen-activated protein kinase cascade. 12, 13 Miyamoto et al. 14 reported that baicalein also blocked the synthesis and secretion of leukotrienes C and D in the guinea pig lung by inhibiting lipoxygenase.
Adipogenesis, which is critical in controlling the body fat mass, is known to progress via two stages. The first is the differentiation of preadipocytes to adipocytes, while the second involves the accumulation of fat in adipocytes. 15 Many gene products, including fatty acid binding protein (FABP), fatty acid synthase, glucose transporter 4, and apolipoproteins, are involved in adipocyte differentiation and fat accumulation. [16] [17] [18] [19] The expressions of these genes are regulated by transcription factors including peroxisomal proliferation-activating receptor-␥ (PPAR␥) and the CCAAT enhancer binding proteins (C/EBPs). 19, 20 Adipogenesis has been studied extensively in vitro using preadipocyte cell lines, including 3T3-L1. 21 When cultured in defined media, 3T3-L1 cells deposit triglycerides in cytoplasmic lipid droplets and express genes that are expressed in adipocytes in vivo. [22] [23] [24] [25] [26] In this study, we showed, by using the 3T3-L1 preadipocyte in vitro system, that baicalein effectively inhibits adipogenesis, possibly by altering the expression of adipogenic genes, including cyclooxygenase (COX)-2.
MATERIALS AND METHODS

Cell culture and reagents
3T3-L1 cells obtained from the Korean Cell Line Bank (Seoul, Korea) were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum, 100 g/mL streptomycin, and 100 units/mL penicillin. The cells were fed with fresh medium every 2 days and subcultured when they reached a confluence of 80%. Baicalein and NS-398 were purchased from Sigma Chemical Co. (St. Louis, MO).
Induction of adipogenesis in 3T3-L1 cells
Confluent cells were cultured with differentiation induction medium (1 g/mL insulin, 0.25 M dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine in Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum) for 2 days, after which they were maintained in differentiation maintenance medium (1 g/mL insulin in Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum). The medium was changed every 2 days until the cells were harvested. To test the effect of baicalein, it was added to the differentiation induction medium and the differentiation maintenance medium until the cells were harvested. Cell viability was measured by the 3-(4,5-dimethylthiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) method as described. 27 
Oil Red O staining
Cells were washed with phosphate-buffered saline (PBS), fixed in 4% (wt/vol) paraformaldehyde for 1 hour, and stained with Oil Red O as described by Kasturi and Joshi. 28 After two washes with PBS, the fat droplets in the cells were observed under an inverted light microscope.
Triglyceride content assay
Differentiated cells in six-well plates were harvested in 500 L of PBS, frozen, and then sonicated. The triglyceride levels in the sonicates were measured by using the TRIGlYZYME-V reaction kit (Shinyang Chemical Co., Seoul, Korea) according to the manufacturer's instructions.
Microarray assay
Total RNA was extracted from 3T3-L1 cells by the acidphenol method using Trizol (GibcoBRL, Burlington, ON, Canada), and double-stranded cDNA was synthesized by using the SuperScript Choice system (LifeTechnologies, Gaithersburg, MD). After cDNA synthesis, unincorporated deoxyribonucleotide triphosphates were removed, and the cDNA was labeled with biotin by using a GeneChip IVT labeling kit (Affymetrix Inc., Santa Clara, CA). Mouse oligonucleotide chips were obtained from Affymetrix, Inc., and assays were conducted according to the manufacturer's instructions. The array was scanned by using an Agilent GeneArray Scanner from Affymetrix, Inc., and the data were analyzed by using ImaGene software (BioDiscovery Co., Boston, MA).
Real-time polymerase chain reaction (PCR)
Total RNA was extracted by the acid-phenol method using Trizol (GibcoBRL), and 1 g was reverse-transcribed for 60 minutes at 42°C using reverse transcription premix (Bioneer, Daejeon, Korea). PCR was performed in 25-L reaction volume containing SYBR Green PCR Mastermix (Qiagen, Hilden, Germany), 2 L of cDNA, and 1 M each primer. The reaction mixtures were preheated at 95°C for 15 minutes and then subjected to 40 cycles of (melting at 95°C for 30 seconds, annealing at 60°C for 30 seconds, elongation at 72°C for 30 seconds) and measurements at 72°C for 20 seconds using a Roter-gene 2000 real-time cycler (Corbett, Mortlake, NSW, Australia). The upstream and downstream primers used were, respectively, as follows: COX-2, 5Ј-AAGACTTGCCAGGCTGAACT-3Ј and 5Ј-C-TTCTGCAGTCCAGGTTCAA-3Ј; FABP, 5ЈCCTCGAA-GGTTTACAAAATG-3Ј and 5ЈGAAGTCACGCCTTTC-ATAAC-3Ј; insulin-like growth factor-2 (IGF-2), 5Ј-T-TGGTGCTTCTCATCTCTTT-3Ј and 5Ј-GTCTCCAGG-TGTCATATTGG-3Ј; apolipoprotein D (ApoD), 5Ј-GAAA-GGAAACTGCATTCAAG-3Ј and 5Ј-CTGGAGGGAGAT-AAGGATTT-3Ј; and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (used as an internal standard), 5Ј-CTA-CATGGTCTACATGTTCC-3Ј and 5Ј-CTGACAATCTTG-AGTGAGTT-3Ј.
Protein extraction and western blot
Cells were harvested using a cell scraper and lysed in a lysis buffer [20 mM Tris (pH 7.4), 5 mM EDTA, 0.1% Triton X-100, and 0.01% 2-mercaptoethanol]. The lysates were then sonicated and centrifuged (13,000 g for 20 minutes at 4°C) to remove insoluble material. The supernatant was transferred to a new tube and stored at Ϫ20°C until analysis. The protein content was determined by using the BioRad DC Protein Assay (Bio-Rad Laboratories Ltd., Hercules, CA). Protein extracts (20 g ) were heated at 95°C for 3 minutes, resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and electrotransferred to nitrocellulose membranes at 80 V for 2 h by using a semidry transfer (Bio-Rad Laboratories). The membranes were then
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CHA ET AL. blocked for 2 hours at room temperature with Tris-buffered saline containing 5% albumin and 0.1% Tween 20, and then incubated with anti-COX-2 antibody (diluted 1:1,000) (TAKARA, Shiga, Japan) for 3 hours at room temperature and subsequently with horseradish peroxidase-conjugated anti-rabbit secondary antibody (diluted 1:3,000) (Amersham Biosciences UK, Buckinghamshire, UK) for 1 hour at room temperature. Peroxidase activity was visualized by using an ECL kit (Amersham Biosciences). Actin was used as an equal loading control.
COX-2 activity assay
Cells were harvested and sonicated in PBS. COX-2 activity was measured by using a COX activity assay kit (Cayman Chemical Co., Ann Arbor, MI) according to the manufacturer's instructions.
Statistical analysis
The data were expressed as means Ϯ SD from at least three independent experiments. Statistical significance was Inhibition of FABP mRNA expression by baicalein. The preadipocytes were differentiated for 2 days with various concentrations of baicalein, and their total RNAs were subjected to real-time PCR. These data were normalized on the basis of the untreated adipocyte value. DMSO, dimethyl sulfoxide. (E) Effects of baicalein on cell viability during adipogenesis. The preadipocytes were differentiated for 2 days with various concentrations of baicalein, and cell viability was detected by MTT assay. The data were analyzed statistically by t tests and one-way ANOVA. *P Ͻ .05, **P Ͻ .01, ***P Ͻ .001 compared with untreated adipocytes.
analyzed by Student's t test and one-way analysis of variance (ANOVA) using SPSS Version 10.0 (SPSS Inc., Chicago, IL).
RESULTS
Baicalein blocks triglyceride accumulation during adipogenesis
As adipocytes differentiate, their intracellular levels of triglyceride increase continuously. We found that baicalein effectively prevented this triglyceride accumulation in differentiating 3T3-L1 preadipocytes ( Fig. 2A) . Baicalein at concentrations of more than 100 M significantly decreased triglyceride accumulation (Fig. 2B) . Microscopic observation of the Oil Red O-stained adipocytes revealed that baicalein significantly decreased the formation of intracellular fat deposits (Fig. 2C) . The mRNA expression of the free fatty acid transporter (FABP), a wellknown marker of adipogenesis, 19 was also decreased by baicalein (Fig. 2D ). When cell viability was measured by using the MTT method, we found that baicalein had no effect on cell viability at 100 M (Fig. 2E) . Thus, the inhibitory effect of baicalein on fat accumulation is not due to its cytotoxicity.
Effect of baicalein on gene expression during adipogenesis
To elucidate the molecular mechanism behind the antiadipogenic effect of baicalein, we sought to identify the genes whose expressions were altered by baicalein. To do this, preadipocytes were differentiated for 7 days with or without baicalein, and their total RNAs were subjected to microarray analyses. Of the 14,110 genes on the microarrays, about 462 genes were up-or down-regulated by over threefold during adipocyte differentiation. Some that were also up-or down-regulated by over threefold during adipogenesis and showed altered expression patterns due to baicalein are listed in Tables 1 and 2 , respectively.
The microarray assay showed that, among genes involved in lipid metabolism, ApoD and FABP mRNA expressions were increased by over ninefold in differentiated adipocytes compared with preadipocytes, which confirms previous reports. 19, 29, 30 The expression of phospholipid scramblase 2 was also significantly elevated. IGF-2, which regulates cell
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CHA ET AL. Shown are the ratios of the microarray signals of untreated and baicalein-treated adipocytes relative to the preadipocyte signal. The biological functions of the genes were obtained from https://www.affymetrix.com/analysis/netaffx/index.affx. cycle, and matrix metalloproteinase 2, which cleaves extracellular matrix, were also highly up-regulated during adipogenesis. Baicalein effectively blocked the increased expressions of these adipogenesis-related genes (Table 1 ). In addition, the mRNA levels of COX-2, which regulates prostaglandin synthesis, were decreased by more than threefold during adipogenesis, as previously reported, 31, 32 while the expression of -protocadherin, plakophilin 1, and trophinin, which are components of cell adhesion molecules, were also down-regulated during adipogenesis. Baicalein reversed these patterns (Table 2) .
To verify the microarray results, we examined COX-2, IGF-2, FABP, and ApoD gene expression during adipogenesis and the effects of baicalein on this by real-time PCR experiments. It was confirmed that COX-2 mRNA expression was significantly decreased during adipogenesis and that baicalein restored it to preadipocyte levels (Fig. 3A) . The expressions of IGF-2, FABP, and ApoD were also confirmed to be up-regulated during adipogenesis and reduced to preadipocyte levels by baicalein treatment (Fig. 3B-D) .
Baicalein restoration of mRNA expression and protein level of COX-2 during adipogenesis
The expression of COX-2 mRNA during adipogenesis with and without baicalein was analyzed by a time course real-time PCR experiment. This revealed that the effect of baicalein was most evident at day 2, namely, at the early phase of adipogenesis (Fig. 4A) . To confirm that the baicalein-induced increase in COX-2 mRNA expression reflects an increase in COX-2 protein levels, COX-2 protein levels were quantified by western blotting. A time course experiment revealed that baicalein had its strongest effect at day 2 (Fig. 4B) , similar to what was observed for the mRNA levels.
Baicalein induces recovery of COX-2 activity during adipogenesis
We performed a COX-2 activity assay and found that during adipogenesis, COX-2 activity steadily decreased during adipogenesis, but it was reversed by baicalein (Fig. 5A ). The concentration of baicalein able to increase COX-2 activity was more than 100 M (Fig. 5B) .
COX-2 inhibitor induces recovery of baicaleininhibited adipogenesis
To confirm that the inhibitory effects of baicalein on adipogenesis are mediated by the restoration of COX-2 activity, a COX-2 inhibitor, NS-398, used to treat the cells along with baicalein during adipogenesis. Triglyceride content, which was decreased in adipocytes by baicalein, was significantly restored by the COX-2 inhibitor in a dose-depen- Shown are the ratios of the microarray signals of untreated and baicalein-treated adipocytes relative to the preadipocyte signal. The biological functions of the genes were obtained from https://www.affymetrix.com/analysis/netaffx/index.affx.
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FIG. 4.
Baicalein-induced restoration of COX-2 mRNA and protein expression during adipogenesis. The time course is shown of COX-2 mRNA expression (A) and COX-2 protein level (B) during adipogenesis and the effect of baicalein. The preadipocytes were differentiated for 2, 4, and 7 days with or without 100 M baicalein. COX-2 mRNA expressions were obtained by real-time PCR experiments, and protein levels were quantified by western blot. The data were analyzed statistically by t test. *P Ͻ .05, **P Ͻ .01 compared with the control value. Actin was used as an equal loading control. dent manner up to 77% of the untreated adipocyte level (Fig.  6) , showing that the inhibitory effect of baicalein is mediated, at least partially, by COX-2 regulation.
DISCUSSION
Baicalein is one of the major flavonoids in S. baicalensis. It is well known for its ability to affect cell proliferation, apoptosis, and inflammation. 1, 5, 8, 9 Here, we show that it also inhibits adipocyte differentiation. It was found that baicalein significantly inhibited triglyceride accumulation in adipocytes during adipogenesis and decreased FABP mRNA expression, which is a well-known marker of adipogenesis ( Fig. 2B and D) . 19 To elucidate the mechanism behind the effect of baicalein, we used a microarray assay to search for the genes that are up-or down-regulated during adipogenesis and then found genes whose expression patterns are altered by baicalein. We found that 462 of the 14,100 genes on the microarray were up-or down-regulated by over threefold during adipogenesis. Of these, FABP, ApoD, and C/EBP␣, which have been reported to induce adipogenesis and triglyceride accumulation in adipocytes, 19, 20, 29 and IGF-2, a growth factor that activates cell proliferation, were up-regulated by over ninefold in differentiated adipocytes compared with preadipocytes, but were significantly downregulated by baicalein treatment ( Table 1 ). The expression of metalloproteinase 2, which is involved in cleaving the extracellular matrix, was also increased by about fivefold during adipogenesis, but was decreased to the level in preadipocytes by baicalein treatment. The latter observation is in agreement with the report of Liu et al., 33 who showed that baicalein down-regulates metalloproteinase 2 mRNA expression and inhibits cell proliferation. Cell adhesion molecules, including -protocadherin, plakophilin 1, and trophinin, were downregulated during adipogenesis, and this action was reversed by baicalein (Table 2 ). In addition, adipogenesis was accompanied by a significant decrease of COX-2 expression, which is in agreement with other studies, 31, 32 expression, protein levels, and enzymatic activity were all reversed by baicalein (Figs. 4 and 5) .
The COXs catalyze the rate-limiting and first committed step of prostanoid biosynthesis. The availability of this enzyme is directly related to the level of prostaglandin production. Two COX isoforms have been identified, namely, COX-1, a constitutive form, and COX-2, an inducible form. While the former is believed to be responsible for homeostasis, the latter is thought to be mainly involved in pathological conditions. 34, 35 A recent study suggested that COX-2 may be involved in body fat regulation and may inhibit adipogenesis. Mice that are heterozygous for the COX-2 gene (Cox-2 ϩ/Ϫ) showed a 3.5-fold increase in their fat pad compared with wild-type mice (Cox-2 ϩ/ϩ). 36 Moreover, Yan et al. 31 reported that COX-2 mRNA expression in 3T3-L1 cells was decreased during adipogenesis but that tumor necrosis factor-␣ (TNF-␣) reversed this effect in a dose-dependent manner. TNF-␣ is known to induce COX-2 expression. When 3T3-L1 cells were treated simultaneously with TNF-␣ and NS-398, an inhibitor of COX-2, the adipogenesis that had been inhibited by TNF-␣ started to progress again. This means that the inhibition of adipogenesis by TNF-␣ is mediated by COX-2. Arachidonic acid is also known to inhibit adipogenesis, and it was reported that this effect is also mediated by COX-2. 31, 32, [37] [38] [39] In addition, Banerjee et al. 40 showed that nimesulide, a COX-2 inhibitor, induces the expression of PPAR␥, which is a transcription factor that plays a major role in adipogenesis. In this study, a COX-2 inhibitor, NS-398, restored triglyceride accumulation in adipocytes, which was inhibited by baicalein (Fig.  6 ). The products of COX-2, prostaglandins, have also been reported to inhibit adipogenesis. Prostaglandin F2␣ is known to activate p42/p44 mitogen-activated protein kinase, which decreases PPAR␥ mRNA expression and thereby inhibits adipogenesis. 41 Moreover, prostaglandin E2 is also known to have an anti-adipogenic effect. 36 Thus, the results of this study agree with previous observations regarding the inhibitory role of COX-2 in adipogenesis, and suggest that the anti-adipogenic effect of baicalein is mediated by the restoration of COX-2 expression.
